Delivery Order SPE2DB24D1034-SPE2DB25FWFV1
- Not listed
- On September 22, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,014.24 to AmerisourceBergen Drug Corp for the supply of Zymfentra 120 mg/ml pens in a two-pack configuration. This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, represents a non-competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies valued at $1,503.56 on August 27, 2025. The order encompasses Zymfentra 120 mg/ml pens in a 2-pack quantity, with an ultimate completion date of September 18, 2025. This non-set-aside contract utilizes firm fixed price pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is structured as a child contract...
- The Defense Logistics Agency awarded a $1,503.56 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen (2-pack) with a completion date of September 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was issued on September 9, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Zymfentra 120 mg/ml pen (2-packs) with a ceiling value of $3,007.12. This firm fixed price delivery order is scheduled for completion by September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,503.56 on July 24, 2025, for Zymfentra 120 mg/ml pens (2-packs), with an ultimate completion date of August 14, 2025. This non-set-aside contract utilizes firm fixed pricing and represents performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $6,014.24 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Zymfentra 120 mg/ml pens (2-pack). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 25, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on September 26, 2025, for Zymfentra 120 mg/ml pen kits valued at $3,007.12. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of October 20, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for...
- The Defense Logistics Agency awarded a $1,503.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen (2-pack) pharmaceutical supplies on September 29, 2025, with completion targeted for October 21, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026....
- The Defense Logistics Agency awarded a $3,007.12 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zymfentra 120 mg/ml pen (2-pack units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 21, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen (2-pack) pharmaceutical supplies. This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under a larger indefinite...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB25FWFV1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Zymfentra 120 mg/mL pens in a two-pack quantity, with a ceiling value of $1,503.56 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of October 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA IDC enables it to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers worldwide. This specific delivery order represents one of many competitively awarded transactions under the larger prime contract vehicle, demonstrating AmerisourceBergen's established capability to meet federal pharmaceutical supply requirements with consistent firm fixed pricing arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/16/25 |